uk: draft guidance on drug to treat advanced prostate cancer

UK: NICE published draft guidance in which enzalutamide is not recommended as a drug to treat advanced prostate cancer.  It says enzalutamide. also called Xtandi, manufactured by Astellas Pharma) is not a cost effective, pre chemotherapy treatment with too many uncertainties associated with evidence provided by manufacturer.  …more

Read More

uk: Two eye treatments for serious diabetic eye conditions

Two eye treatments for serious diabetic eye condition – final draft guidance NICE recommended aflibercept solution for injection (Eylea, Bayer Pharma), and dexamethasone intravitreal(i) implant (Ozurdex, Allergan) as possible treatment options for some people with diabetic macular oedema, in two separate pieces of final draft guidance published (2 June). This oedema is a common complication…

Read More

8th European Public Health Conference

Event 8th European Public Health Conference Wed., 14 – 17th Oct 2015, MiCo Milano Congressi, Milan, Italy Organized by the European Public Health Conference Foundation, the European Public Health Association (EUPHA) and the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI). The event will contribute to improving public health in Europe by offering…

Read More

uk: Recommendation for knee cartilage treatment

Research recommendation for knee cartilage treatment NICE has opened a public consultation on draft guidance on a procedure which aims to repair defects in knee cartilage. This procedure is autologous chondrocyte implantation (ACI) and recommends that this is used only in research, as more evidence is needed on how it works in longer term and…

Read More

UK: Treatment guides for treating kidney and prostate cancer

Final guidance on use of axitinib for treating kidney cancer and sipuleucel-T for prostate cancer. Guidance issued to the NHS today, recommends that the drug axitinib, known as Inlyta by Pfizer, should be available as a second line treatment for kidney cancer. A separate new guide did not recommended sipuleucel-T, known as Provenge, for treating…

Read More

UK: Dexamethasone treatment for diabetic eye condition

Dexamethasone treatment of common diabetic eye condition. NICE is recommending dexamethasone (Ozurdex, Allergan) intravitreal(1) implant, for the treatment of diabetic macular oedema (DMO) in preliminary recommendations published 20/02/ 2015. The draft guidance recommends dexamethasone as a treatment option in people only where:  the implant is to be used in an eye with an intraocular (pseudophakic)(2)…

Read More

New treatment for advanced kidney cancer!

NHS recommended new treatment for some patients with advanced kidney cancer   NICE, the healthcare guidance body issued new final draft guidance recommending axitinib (Inlyta, Pfizer), for advanced kidney cancer [1]. Renal cell carcinoma, a kidney cancer that starts in cells lining the small tubes that help to make urine. In the advanced state, cancer…

Read More

€69bn per year = Gender violence!

MEP’s call for action on violence against women. After the recent International Day for the Elimination of Violence Against Women, EU members of parliament’s women’s rights and gender equality committee urged all member states to adopt tougher, more harmonised legislation against gender based violence. Iratxe García Pérez, Chair of the Committee said “Seven women a…

Read More

Guidance recommends imatinib for digestive system cancers

New guidance recommends imatinib for digestive system cancers NICE final guidance to NHS recommending imatinib, also known as Glivec and made by Novartis, for up to 3 years for people who have had a gastro intestinal stromal tumour (GIST) removed and are at high risk of the cancer recurring. GISTs are found imost commonly in…

Read More

EUGenMed Project

The European Institute of Women’s Health is a project partner in EUgenmed. The Eugenmed project intends to complete the following activities: Research addressing sex and gender (S&G) in biomedical sciences and health care research is emerging as a novel and highly promising field. Interaction of S&G related mechanisms leads to different manifestation of frequent diseases…

Read More